trial

Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)

NCTId NCT00453609
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 15 (actual)
Sponsored by State University of New York - Upstate Medical University
Primary completion 2008-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
15 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Single Group
Masking
None
Start
2007-04
Primary completion
2008-10
Eligibility
ALL · 18 Years · 69 Years

Interventions & indications

Drugs
long-lasting injectable naltrexone

Sponsors

State University of New York - Upstate Medical UniversityLead Sponsor

Investigators

1
Steven L Batki, MDPrincipal Investigator

Sites

3 total
Syracuse, United StatesSyracuse, United StatesSyracuse, United States

Facts & assertions

4 sourced
Enrollment
15
Phase
PHASE4
Primary Completion Date
2008-10
Status
COMPLETED
relationships
The graph out of here
drug
long-lasting injectable naltrexone
drug
lead_sponsor
State University of New York - Upstate Medical University
company
indication
Bipolar Disorder
indication
Schizoaffective Disorder
indication
Alcohol Dependence
indication
investigator
Steven L Batki, MD
person